Inactivation of Prostaglandin E2 as a Mechanism for UGT2B17-Mediated Adverse Effects in Chronic Lymphocytic Leukemia

Éric P. Allain(Centre hospitalier universitaire de Québec), Chantal Guillemette(Centre hospitalier universitaire de Québec)
Frontiers in Oncology
July 4, 2019
10.3389/fonc.2019.00606
Cited by 22

Related Papers

A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome
|Cells|2023|5